Ireland
--:--IST
Latest
Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide
Priya Life Science Clinical trial register
TrackersDrugsComparisonsAPI
Trackers› Clinical trials› Paris
Clinical trial register · France

Clinical Trials in Paris, 2026

Every study on the ClinicalTrials.gov registry that lists a site in France and is open, about to open, active-but-closed, or enrolling by invitation. Filter it, cite it, and take it away as a file.

Download CSV
Source: ClinicalTrials.gov, U.S. National Library of Medicine. Complete coverage — all 9697 matching records held by the registry are in this view. Synced 26 Oct 2026, 03:20 UTC
9697
Studies in scope
all four open statuses
6025
Recruiting now
open to new participants
1033
Lead sponsors
across recruiting studies
Top sites
Paris 2821 Lyon 1392 Bordeaux 1389 Marseille 1285 Lille 1282
Narrow the registerReset
Recruitment status
Phase
Lead sponsor
Assistance Publique - Hôpitaux de Paris602 Novartis Pharmaceuticals68 Fondation Ophtalmologique Adolphe de Rothschild66 AstraZeneca64 Institut National de la Santé Et de la Recherche Médicale, France63
Site location
Paris2821 Lyon1392 Bordeaux1389 Marseille1285 Lille1282
All 804 locations
Target enrolment
to

Trials with a site in Paris

2821 of 9697 studies
Download
Status
Study
Lead sponsor
Phase
Enrol
Sites in France
Start
Recruiting
Centre Hospitalier de Saint-Denis
Observational
242
Paris, Saint-Denis
2025-02-20
Recruiting
SharpTx
Not applicable
170
Paris
2025-02-20
Recruiting
Assistance Publique - Hôpitaux de Paris
Not applicable
50
Paris
2025-02-20
Active, closed
Centre Hospitalier St Anne
Not applicable
200
Paris
2025-02-20
Recruiting
Lymphocyte-Sparing And Radio-Immunotherapy in Head and Neck Carcinoma
NCT06706401Oropharynx Cancer, Larynx Cancer, Hypopharynx Cancer, Primary Head and Neck Tumor
DrugsVesanoid·ATRA·Cetuximab·Cisplatin
Centre Leon Berard
Phase 3
460
Lyon, Vandœuvre-lès-Nancy, Villejuif, Angers, Lille, Nice, Paris, Reims
2025-02-20
Recruiting
Novartis Pharmaceuticals
Phase 2
20
Bordeaux, Lille, Lyon, Nantes, Paris, Vandœuvre-lès-Nancy
2025-02-18
Recruiting
Hopital Foch
Phase 2
35
Marseille, Nantes, Paris, Suresnes
2025-02-18
Recruiting
Menarini Group
Phase 2
44
Nantes, Nice, Paris, Tours
2025-02-18
Recruiting
Novo Nordisk A/S
Phase 3
510
Bobigny, Bordeaux, Créteil, Grenoble, Lyon, Paris, Rouen
2025-02-17
Not yet open
Ventilation of the Extremely Premature Infants Optimized by Dead Space Washout
NCT06334523Extremely Low Birthweight Infant, Continuous Tracheal Gas Insufflation, Medical Device, Lung Protection
Centre Hospitalier Intercommunal Creteil
Not applicable
144
Créteil, Nantes, Paris
2025-02-13
By invitation
Longboard Pharmaceuticals
Phase 3
324
Strasbourg, Bron, Lille, Marseille, Paris, Toulouse
2025-02-12
Recruiting
Assistance Publique - Hôpitaux de Paris
Phase 3
1,300
Paris
2025-02-11
Recruiting
Association pour la promotion de la recherche en maladies infectieuses et tropicales dans le Loiret
Observational
120
Caen, La Roche-sur-Yon, Lyon, Nantes, Niort, Orléans, Paris, Poitiers
2025-02-11
Active, closed
Assistance Publique - Hôpitaux de Paris
Not applicable
918
Paris
2025-02-11
Recruiting
Home-based Cycling for People With Lumbar Spinal Stenosis
NCT04075539Symptomatic Lumbar Spinal Stenosis
Assistance Publique - Hôpitaux de Paris
Phase 3
302
Paris
2025-02-10
Recruiting
European Georges Pompidou Hospital
Observational
50
Paris
2025-02-10
Recruiting
Dianthus Therapeutics
Phase 3
256
Bordeaux, Brest, Bron, Clermont-Ferrand, Libourne, Marseille, Nice, Paris
2025-02-10
Active, closed
Genmab
Phase 3
584
Nice, Paris, Pierre-Bénite, Rennes, Saint-Herblain, Toulouse, Villejuif
2025-02-07
Recruiting
Takeda
Phase 2
96
Montpellier, Nantes, Paris
2025-02-07
Active, closed
Novartis Pharmaceuticals
Phase 3
180
Bordeaux, Nice, Paris, Strasbourg, Toulouse
2025-02-07
Recruiting
LEO Pharma
Phase 3
90
Antony, Lyon, Nice, Paris
2025-02-05
By invitation
Occlutech International AB
Observational
200
Katowice, Lyon, Marseille, Paris
2025-02-05
Recruiting
Maze Therapeutics
Phase 2
74
Créteil, Lille, Lyon, Paris, Saint-Ouen
2025-02-05
Recruiting
Topadur Pharma AG
Phase 2
15
Bordeaux, La Tronche, Lille, Paris
2025-02-04
Recruiting
Bristol-Myers Squibb
Phase 1/2
416
Nice, Bordeaux, Lyon, Marseille, Caen, Montpellier, Villejuif, Paris
2025-02-04
Active, closed
Viridian Therapeutics, Inc.
Phase 3
320
Angers, Bron, Paris
2025-02-03
Recruiting
Alcediag
Not applicable
450
Erstein, Issy-les-Moulineaux, La Roche-sur-Foron, Lyon, Montrond-les-Bains, Paris, Ville-d'Avray
2025-02-03
Recruiting
BioNTech SE
Phase 3
621
Angers, Bordeaux, Caen, Paris, Rennes, Saint-Herblain, Toulon
2025-02-03
Recruiting
Airway Therapeutics, Inc.
Phase 2/3
366
Lille, Nancy, Nice, Paris, Poissy
2025-02-03
Recruiting
Fondation Hôpital Saint-Joseph
Observational
30
Paris
2025-02-03
Recruiting
Advanced Bionics AG
Observational
51
Paris
2025-02-03
Recruiting
NovoCure GmbH
Phase 3
741
Bron, Marseille, Paris, Toulouse
2025-02-03
Recruiting
Early and Objective Assessment of Neurological Prognosis in Cardiac Arrest Patients
NCT06387225Cardiac Arrest, Neurologic Symptoms, Intensive Care Neurological Disorder
Nantes University Hospital
Observational
608
La Roche-sur-Yon, Nantes, Paris, Saint-Nazaire
2025-02-02
Not yet open
Assistance Publique - Hôpitaux de Paris
Observational
20
Paris
2025-02
Not yet open
Assistance Publique - Hôpitaux de Paris
Observational
355,000
Paris
2025-02
Not yet open
Institut Cancerologie de l'Ouest
Phase 2
114
Caen, Dijon, Lille, Limoges, Marseille, Montpellier, Paris, Pierre-Bénite
2025-02
Recruiting
Assistance Publique - Hôpitaux de Paris
Observational
22
Paris
2025-01-31
Recruiting
ORal Antibiotics in Acute Mesenteric Ischemia
NCT06387147Acute Mesenteric Ischemia
DrugsGentamicin·Metronidazole
Assistance Publique - Hôpitaux de Paris
Phase 3
196
Clichy, Paris
2025-01-31
Recruiting
A Study of AZD0486 Monotherapy or in Combination With Other Anti-Cancer Agents for Mature B-Cell Malignancies
NCT06564038Chronic Lymphocytic Leukaemia, Small Lymphocytic Lymphoma, Mantle-cell Lymphoma, Large B-cell Lymphoma
DrugsSurovatamig·Acalabrutinib·Vincristine·Doxorubicin
AstraZeneca
Phase 1/2
408
Clermont-Ferrand, Montpellier, Paris, Saint-Cloud, Villejuif
2025-01-30
Active, closed
DEO NV
Observational
10
Paris
2025-01-30
Not yet open
Assistance Publique - Hôpitaux de Paris
Observational
200
Paris
2025-01-30
Active, closed
Study of Anti-CEACAM5 ADC M9140 in Participants With Advanced Solid Tumors (PROCEADE PanTumor)
NCT06710132Solid Tumors, Gastric Cancer, Non-Small Cell Lung Cancer (NSCLC), Pancreatic Cancer
DrugM9140
EMD Serono Research & Development Institute, Inc.
Phase 1/2
184
Bordeaux, Dijon, Lille, Paris, Saint-Herblain, Suresnes, Toulouse, Villejuif
2025-01-29
Active, closed
Definium Therapeutics US, Inc.
Phase 3
245
Douai, Marseille, Paris, Sotteville-lès-Rouen
2025-01-29
Recruiting
FORTIFI-HN01: A Study of Ficerafusp Alfa (BCA101) or Placebo in Combination With Pembrolizumab in First-Line PD-L1-pos, R or M HNSCC
NCT06788990Metastatic Head and Neck Squamous Cell Carcinoma, Recurrent Head and Neck Squamous Cell Carcinoma
DrugsFicerafusp alfa·Keytruda·Pembrolizumab
Bicara Therapeutics
Phase 2/3
650
Amiens, Bordeaux, Lille, Lyon, Paris, Rennes, Saint-Grégoire, Strasbourg
2025-01-28
Recruiting
Optimizing Bronchopulmonary Cancer Screening
NCT06439901Bronchopulmonary Disease, Diagnoses Disease
Institut Curie
Not applicable
500
Bobigny, Gentilly, Issy-les-Moulineaux, Malakoff, Paris
2025-01-27
Recruiting
ANRS, Emerging Infectious Diseases
Phase 3
610
Bordeaux, Montpellier, Nantes, Paris
2025-01-27
Recruiting
Assistance Publique - Hôpitaux de Paris
Phase 2
52
Paris, Amiens, Angers, Besançon, Bordeaux, Caen, Clamart, Clermont-Ferrand
2025-01-24
Recruiting
Ascentage Pharma Group Inc.
Phase 3
490
Angers, Le Mans, Limoges, Nantes, Nice, Orléans, Paris, Pessac
2025-01-22
Active, closed
Institut de Recherches Internationales Servier
Phase 1/2
51
Lyon, Paris, Toulouse
2025-01-22
Recruiting
Institut National de la Santé Et de la Recherche Médicale, France
Not applicable
1
Paris
2025-01-21
Recruiting
Theravia
Phase 2
50
Créteil, Jossigny, Le Kremlin-Bicêtre, Lyon, Paris, Saint-Denis
2025-01-21
Recruiting
Incyte Corporation
Phase 3
240
Amiens, Marseille, Nancy, Nantes, Nice, Paris, Pierre-Bénite, Toulouse
2025-01-21
Recruiting
Assistance Publique - Hôpitaux de Paris
Observational
20
Paris
2025-01-21
Recruiting
Pfizer
Not applicable
90
Toulouse, Paris, Aix-en-Provence, Albi, Amiens, Avignon, Bordeaux, Brest
2025-01-20
Recruiting
Choroid Plexus Dysfunction in Neurological Diseases
NCT06403189Plexus Choroideus, Metabolic Syndrome
Assistance Publique - Hôpitaux de Paris
Not applicable
65
Paris
2025-01-20
Not yet open
University Hospital, Bordeaux
Not applicable
252
Bordeaux, Boulogne-Billancourt, Castelnau-le-Lez, Dijon, Grenoble, Lyon, Nice, Paris
2025-01-15
Active, closed
argenx
Phase 3
631
Marseille, Orléans, Lyon, Paris
2025-01-15
Not yet open
Impact of Uterine Immune Profiling and Personalized Treatments in Patients Receiving a Single Blastocyst: a Matched Controlled Study
NCT06503952Infertility, Success Rate of Assisted Reproductive Therapy, Single Embryo Transfer, Pregnancy Outcomes
Matricelab Innove
Observational
340
Paris
2025-01-15
Recruiting
GCS-CCOMS
Not applicable
6,500
Armentières, Bailleul, Étampes, Laxou, Lille, Nanterre, Paris, Rouffach
2025-01-15
Recruiting
Immatics US, Inc.
Phase 3
360
Lille, Paris, Villejuif
2025-01-14
Recruiting
Novo Nordisk A/S
Phase 3
480
Créteil, Lyon, Paris
2025-01-10
Recruiting
BeOne Medicines
Phase 1
695
Bordeaux, Marseille, Paris, Saint-Herblain, Villejuif
2025-01-10
Recruiting
Galimedix Therapeutics Inc
Phase 2
110
Bordeaux, Lyon, Marseille, Paris, Tours
2025-01-10
Recruiting
Assistance Publique - Hôpitaux de Paris
Phase 2
21
Paris
2025-01-10
Recruiting
Preoxygenation for Tracheal Aspirations in Intensive Care
NCT06421012ICU Patients Under Invasive Mechanical Ventilation
Assistance Publique - Hôpitaux de Paris
Not applicable
2,260
Paris
2025-01-07
Active, closed
Daiichi Sankyo
Phase 2
335
Caen, Dijon, Lille, Lyon, Paris, Plérin, Saint-Herblain, Toulouse
2025-01-06
Recruiting
Fluid Responsiveness and Venous Congestion Evolution During Volume Expansion
NCT06772038Hemodynamic, Fluid Responsiveness, Venous Congestion, Fluid Challenge
Bicetre Hospital
Observational
64
Paris
2025-01-05
Recruiting
Assistance Publique - Hôpitaux de Paris
Observational
1,500
Paris
2025-01-02
Recruiting
Clinique Bizet
Not applicable
40
Paris
2025-01-02
Recruiting
Automatic Phenotyping of Patients on 2D Photography
NCT06219421Dysmorphia, Orphan Diseases, Dysmorphies Craniofaciales
Imagine Institute
Observational
22,000
Paris
2025-01-01
Not yet open
Prevalence and Severity of Cramps in Chronic Kidney Disease Patients
NCT06737094Cramps, Chronic Kidney Disease(CKD)
Assistance Publique - Hôpitaux de Paris
Observational
250
Paris
2025-01
Not yet open
Assistance Publique - Hôpitaux de Paris
Not applicable
238
Paris
2025-01
Recruiting
Santen SAS
Phase 3
234
Bordeaux, Guillon, Paris, Saint-Etienne
2024-12-30
Recruiting
ECD-Score: a Study on Erdheim-Chester Disease
NCT07454343Erdheim-Chester Disease (ECD)
Meyer Children's Hospital IRCCS
Observational
1,000
Paris
2024-12-23
Recruiting
Real-world Clinical Response to Cenobamate Early add-on in France, Germany and Spain
NCT06716801Focal Epilepsy With and Without Secondary Generalization
DrugCenobamate
Aziende Chimiche Riunite Angelini Francesco S.p.A
Observational
300
Paris
2024-12-19
Recruiting
Assistance Publique - Hôpitaux de Paris
Observational
434
Paris
2024-12-19
Recruiting
Centre Hospitalier Universitaire de Saint Etienne
Phase 4
180
Caluire-et-Cuire, La Roche-sur-Yon, Lomme, Montpellier, Paris, Reims, Saint-Etienne, Tours
2024-12-19
Active, closed
Vertex Pharmaceuticals Incorporated
Observational
401
Brest, Paris
2024-12-19
Recruiting
Assistance Publique - Hôpitaux de Paris
Observational
50
Paris
2024-12-19
Recruiting
Biotronik AG
Observational
200
Paris
2024-12-19
Recruiting
Cutting Edge SAS
Not applicable
57
Marseille, Montauban, Paris
2024-12-19
Recruiting
Assistance Publique - Hôpitaux de Paris
Not applicable
5
Paris
2024-12-19
Active, closed
Detection Algorithm for Recurrence or Relapse of Depression Thanks to a Smartwach
NCT06789822Depressive Disorder, Depressive Disorder, Major Depressive Disorder, Depressive Disorder Not Otherwise Specified (NOS)
Dalia Care
Not applicable
800
Paris
2024-12-19
Recruiting
Sanofi
Phase 2
84
Créteil, Paris
2024-12-19
Recruiting
Nantes University Hospital
Not applicable
170
Bordeaux, Clermont-Ferrand, Grenoble, Lyon, Marseille, Nancy, Nantes, Paris
2024-12-18
Recruiting
Assistance Publique Hopitaux De Marseille
Not applicable
60
Bordeaux, Bron, Lille, Marseille, Paris, Rennes, Toulouse
2024-12-18
Active, closed
Arrowhead Pharmaceuticals
Phase 1
39
Paris
2024-12-17
Active, closed
Phase 2 Study of Rapcabtagene Autoleucel in Myositis
NCT06665256Idiopathic Inflammatory Myopathies
DrugRapcabtagene autoleucel
Novartis Pharmaceuticals
Phase 2
21
Brest, Lille, Lyon, Marseille, Paris, Rennes
2024-12-17
Recruiting
The PERSEVERE Study
NCT06588634Pulmonary Embolism, Pulmonary Thromboembolism
Inari Medical
Not applicable
200
Besançon, La Tronche, Montpellier, Nîmes, Paris
2024-12-16
Recruiting
Phase 1 Study of OP-3136 in Advanced or Metastatic Solid Tumors
NCT06784193Advanced or Metastatic ER+ HER2- Breast Cancer (mBC), Advanced or Metastatic Non-Small Cell Lung Cancer (NSCLC), Advanced or Metastatic Castration-Resistant Prostate Cancer (mCRPC), Metastatic Breast Cancer
DrugsPalazestrant·Fulvestrant
Olema Pharmaceuticals, Inc.
Phase 1
180
Saint-Herblain, Paris, Villejuif
2024-12-16
Recruiting
Study of Ultomiris® (Ravulizumab) Safety in Pregnancy
NCT06312644Ultomiris-exposed Pregnant/ Postpartum, Pregnancy, Paroxysmal Nocturnal Hemoglobinuria (PNH), Atypical Hemolytic Uremic Syndrome (aHUS)
DrugUltomiris
Alexion Pharmaceuticals, Inc.
Observational
75
Paris
2024-12-16
Recruiting
Institut National de la Santé Et de la Recherche Médicale, France
Not applicable
45
Paris, Toulouse
2024-12-13
Recruiting
First in Human Study of TUB-030 in Patients With Advanced Solid Tumors
NCT06657222Advanced Solid Tumors, HNSCC, SCLC, NSCLC
Gilead Sciences
Phase 1/2
250
Paris, Villejuif
2024-12-13
Recruiting
Assistance Publique - Hôpitaux de Paris
Phase 3
318
Paris
2024-12-12
Recruiting
The Leeds Teaching Hospitals NHS Trust
Observational
550
Bordeaux, Brest, Créteil, Massy, Montpellier, Nîmes, Paris, Saint-Cyr-sur-Loire
2024-12-12
Recruiting
Hospices Civils de Lyon
Not applicable
722
Bron, Dijon, Montpellier, Nancy, Paris, Pessac, Rennes, Saint-Herblain
2024-12-12
Active, closed
GlaxoSmithKline
Phase 1
86
Brest, Paris
2024-12-11
Recruiting
Assistance Publique - Hôpitaux de Paris
Not applicable
20
Paris
2024-12-11
Active, closed
Study to Evaluate Ultevursen in Subjects With Retinitis Pigmentosa (RP) Due to Mutations in Exon 13 of the USH2A Gene
NCT06627179Retinitis Pigmentosa (RP), Usher Syndrome Type 2, Deaf Blind, Retinal Disease
Laboratoires Thea
Phase 2
81
Montpellier, Paris
2024-12-11
Active, closed
Observational Study of Patients Treated With Nivolumab and Chemotherapy for Advanced or Metastatic Esophageal, Gastroesophageal or Gastric Cancer in France
NCT06504615Gastric Adenocarcinoma, Gastro-esophageal Junction Adenocarcinoma, Esophageal Adenocarcinoma (EAC), Esophageal Squamous Cell Carcinoma (ESCC)
DrugNivolumab
Bristol-Myers Squibb
Observational
208
Paris
2024-12-10
Active, closed
Ascendis Pharma A/S
Phase 2
25
Paris
2024-12-10
By invitation
Phase 1b Long-term Extension Trial of RAY121 in Immunological Diseases (RAINBOW-LTE Trial)
NCT06723106Antiphospholipid Syndrome (APS), Bullous Pemphigoid (BP), Behçet's Syndrome (BS), Dermatomyositis (DM)
DrugRAY121
Chugai Pharmaceutical
Phase 1
144
Montpellier, Paris
2024-12-09
Recruiting
Observational Study of Travellers Pathologies
NCT06701890Travel-Related Illness
Institut Pasteur
Not applicable
11,000
Paris
2024-12-09
Recruiting
Novartis Pharmaceuticals
Phase 3
60
Marseille, Nantes, Paris
2024-12-09
Recruiting
Assistance Publique - Hôpitaux de Paris
Observational
120
Clamart, Garches, Paris
2024-12-06
Recruiting
Evaluation of the Reproducibility of a Fatigability Test Fitted to Patients With Spinal Muscular Atrophy
NCT06562283Spinal Amyotrophy, Infantile Spinal Muscular Atrophy, Juvenile Spinal Muscular Atrophy
Centre Hospitalier Universitaire de Saint Etienne
Not applicable
80
Saint-Etienne, Lyon, Paris
2024-12-06
Recruiting
Johnson & Johnson Enterprise Innovation Inc.
Phase 2
130
Brest, Marseille, Paris, Rouen, Villejuif
2024-12-06
Recruiting
Institut Curie
Not applicable
110
Paris, Saint-Cloud
2024-12-06
Recruiting
Ryvu Therapeutics SA
Phase 2
178
Le Mans, Lille, Limoges, Lyon, Montpellier, Paris, Pessac
2024-12-05
Recruiting
ENVIEANCILLAIRE: Efficacy of Nirsevimab in Children Hospitalised With RSV Bronchiolitis - A Subsidiary Study on the Immune Signature and Microbial Environment
NCT07698769Mucosal Cytokine Profile of Patients (Type I and III Interferons, Pro-inflammatory Cytokines)
Centre Hospitalier Intercommunal Creteil
Observational
110
Créteil, Paris
2024-12-05
Recruiting
Natural History Study of Children With LAMA2-related Dystrophies
NCT06354790Merosin Deficient Congenital Muscular Dystrophy
Institut de Myologie, France
Observational
40
Garches, Lyon, Montpellier, Paris
2024-12-05
Recruiting
Nosocomial Respiratory Virus Infection
NCT06643039Nosocomial Infections
DrugNasopharyngeal swab
Hospices Civils de Lyon
Not applicable
1,000
Bordeaux, Dijon, Lyon, Paris
2024-12-05
Recruiting
Elacestrant + Everolimus in Patients ER+/HER2-, ESR1mut, Advanced Breast Cancer Progressing to ET and CDK4/6i.
NCT06382948Advanced Breast Cancer, ER-positive Breast Cancer, HER2-negative Breast Cancer, ESR1 Gene Mutation
DrugsElacestrant·Everolimus
MedSIR
Phase 3
300
Bordeau, Bordeaux, Dijon, Limoges, Lyon, Marseille, Paris, Plérin
2024-12-05
Recruiting
Institut de Recherches Internationales Servier
Phase 3
48
Nantes, Nice, Paris, Pessac, Toulouse, Vandœuvre-lès-Nancy
2024-12-03
Active, closed
H. Lundbeck A/S
Phase 3
401
Rennes, Lille, Bordeaux, Montpellier, Toulouse, Marseille, Paris
2024-12-03
By invitation
A Study to Evaluate Vutrisiran in Patients With Transthyretin Amyloidosis With Cardiomyopathy
NCT06679946Transthyretin Amyloidosis (ATTR) With Cardiomyopathy
DrugVutrisiran
Alnylam Pharmaceuticals
Phase 3
700
Créteil, Marseille, Paris, Rennes, Toulouse
2024-12-03
Recruiting
Retrospective Epidemiological Study of Patients in the National Cohort of the French TMA Center
NCT07205861Thrombotic Thrombocytopenic Purpura (TTP), Immune Thrombotic Thrombocytopenic Purpura, Thrombotic Microangiopathies, Microangiopathy, Thromboic
Assistance Publique - Hôpitaux de Paris
Observational
1,200
Paris
2024-12-02
Recruiting
Merck Sharp & Dohme LLC
Phase 3
3,082
Dijon, Saint Priest En Jarez, Pierre-Bénite, Paris
2024-12-02
Not yet open
Almaviva Sante
Not applicable
96
Paris
2024-12-01
Active, closed
Institut National de la Santé Et de la Recherche Médicale, France
Not applicable
60
Paris
2024-11-27
Recruiting
Surovatamig (AZD0486) as Monotherapy in Participants With Relapsed/Refractory (R/R) B-cell NHL
NCT06526793B-cell Non-Hodgkin Lymphoma, Follicular Lymphoma (FL), Large B-Cell Lymphoma (LBCL)
DrugSurovatamig
AstraZeneca
Phase 2
270
Montpellier, Paris, Pierre-Bénite, Rouen
2024-11-27
Recruiting
National Registry of Cardioneuroablation in Recurrent Reflex Syncope
NCT06159764Syncope, Vasovagal, Bradycardia, Heart Arrest
University Hospital, Bordeaux
Observational
50
Bron, Clermont-Ferrand, Lille, Marseille, Montpellier, Paris, Pessac, Rennes
2024-11-27
Recruiting
TBF Genie Tissulaire
Phase 3
116
Brest, Lyon, Marseille, Montpellier, Nantes, Paris, Saint-Priest-en-Jarez, Strasbourg
2024-11-25
Recruiting
CMC Ambroise Paré
Observational
200
Brest, Nantes, Marseille, Neuilly-sur-Seine, Paris
2024-11-25
Recruiting
Clinique Bizet
Not applicable
100
Paris
2024-11-25
Recruiting
Washington University School of Medicine
Phase 2/3
280
Toulouse, Lille, Paris, Bron, Rouen
2024-11-22
Recruiting
Assistance Publique - Hôpitaux de Paris
Not applicable
770
Paris
2024-11-22
Active, closed
BioMarin Pharmaceutical
Phase 2
30
Marseille, Angers, Toulouse, Le Kremlin-Bicêtre, Paris
2024-11-22
Recruiting
Washington University School of Medicine
Phase 2/3
280
Toulouse, Lille, Paris, Bron, Rouen
2024-11-22
Recruiting
Intestinal Akkermansia Muciniphila in Prostate Cancer
NCT06242509Metastatic Castration-resistant Prostate Cancer
Assistance Publique - Hôpitaux de Paris
Observational
52
Paris
2024-11-20
Recruiting
Gérond'if
Observational
258
Cormeilles-en-Parisis, L'Haÿ-les-Roses, Melun, Paris, Rambouillet, Versailles, Villejuif
2024-11-20
Not yet open
Postoperative Extubation in Hypoxemic Patients
NCT06688487Hypoxemia, Extubation, Postoperative Respiratory Complication
Fondation Hôpital Saint-Joseph
Not applicable
152
Argenteuil, Besançon, Le Plessis-Robinson, Montpellier, Paris, Reims, Saint-Denis
2024-11-18
Active, closed
Regeneron Pharmaceuticals
Phase 2
120
Rennes, Toulon, Bayonne, Grenoble, Montpellier, Paris
2024-11-18
Recruiting
Meyer Children's Hospital IRCCS
Not applicable
700
Paris
2024-11-15
Active, closed
A Phase 2 Trial of ENV-101 in Patients With Lung Fibrosis (WHISTLE-PF Trial)
NCT06422884Idiopathic Pulmonary Fibrosis, Progressive Fibrosing Interstitial Lung Disease
DrugTaladegib
Endeavor Biomedicines, Inc.
Phase 2
213
Angers, Bordeaux, Caen, Dijon, Montpellier, Nantes, Paris, Rennes
2024-11-15
Recruiting
Reliability of Minimally Trained Operator's Velocity-Time Integral Measurement Guided by Artificial Intelligence VTI
NCT06486467Velocity-time Integral Measurement, Critically Ill Patients, Tissue Hypoperfusion
Assistance Publique - Hôpitaux de Paris
Not applicable
100
Limoges, Paris
2024-11-14
Recruiting
oCular Examination at Cell RESolution With Optical TransmissionTomography
NCT06976034Glaucoma Associated With Other Ocular Disorders
Centre Hospitalier National d'Ophtalmologie des Quinze-Vingts
Not applicable
300
Paris
2024-11-12
Recruiting
European Organisation for Research and Treatment of Cancer - EORTC
Phase 3
290
Nice, Paris
2024-11-11
Recruiting
Janssen Research & Development, LLC
Phase 3
39
Lille, Paris
2024-11-11
Active, closed
Longboard Pharmaceuticals
Phase 3
367
Lille, Toulouse, Bron, Marseille, Paris, Strasbourg, Villejuif
2024-11-11
Active, closed
argenx
Phase 2
87
Lille, Bordeaux, Marseille, Montpellier, Paris
2024-11-11
Recruiting
Assistance Publique - Hôpitaux de Paris
Phase 2
20
Paris
2024-11-10
Recruiting
New Adjuvant Vaccine in Glioblastoma, a Phase 1/2a Study
NCT06622434Newly Diagnosed Glioblastoma
DrugImmunization
Assistance Publique - Hôpitaux de Paris
Phase 1/2
35
Paris, Marseille
2024-11-08
Recruiting
Fondation Ophtalmologique Adolphe de Rothschild
Observational
123
Paris
2024-11-08
Recruiting
Echosens
Not applicable
153
Orsay, Paris
2024-11-08
Recruiting
Early Assessment of Cardiac Function After Treatment With CAR-T Cells
NCT06350994Car T- Cell, Hematologic Malignancy, Acute Lymphoblastic Leukemia, Lymphoma, B-Cell
Assistance Publique - Hôpitaux de Paris
Observational
60
Paris
2024-11-07
Active, closed
Sanofi
Phase 2
556
Amiens, Lyon, Montpellier, Paris, Pessac, Strasbourg, Toulouse
2024-11-07
Recruiting
Assistance Publique - Hôpitaux de Paris
Observational
410
Paris
2024-11-04
By invitation
Royal Brompton & Harefield NHS Foundation Trust
Observational
1,000
Paris
2024-11-01
Recruiting
Centre Hospitalier National d'Ophtalmologie des Quinze-Vingts
Observational
100
Paris, Caen, Lyon, Marseille, Montpellier, Nîmes, Rennes, Strasbourg
2024-11-01
Not yet open
LEAF4Life, Inc.
Phase 3
310
Paris
2024-11-01
Not yet open
Assistance Publique - Hôpitaux de Paris
Observational
200
Paris
2024-11-01
Recruiting
Assistance Publique - Hôpitaux de Paris
Not applicable
244
Paris
2024-10-31
Recruiting
Centre Hospitalier Universitaire de Saint Etienne
Phase 4
220
Le Kremlin-Bicêtre, Amiens, Lille, Limoges, Marseille, Montpellier, Nice, Paris
2024-10-31
Recruiting
EXtensive mulTilayer stEnt treatmeNt in Aortic disSectiOn
NCT06675617Type B Aortic Dissection
Intressa Vascular SA
Not applicable
72
Bordeaux, Paris
2024-10-30
Active, closed
Novartis Pharmaceuticals
Phase 2
96
Bordeaux, Dijon, Lille, Lyon, Montpellier, Paris, Rennes, Strasbourg
2024-10-29
Active, closed
Eli Lilly and Company
Phase 2
45
Bordeaux, Lille, Lyon, Marseille, Paris, Villejuif
2024-10-25
Recruiting
Peridontal and Intestinal Microbiota in Patients With Gingival Scarring Pemphigoid
NCT06291350Pemphigoid, Benign Mucous Membrane, Gingivitis Hyperplastic
Centre Hospitalier Universitaire de Nice
Observational
45
Nice, Paris
2024-10-24
Recruiting
CMC Ambroise Paré
Observational
200
Brest, Nantes, Marseille, Neuilly-sur-Seine, Paris
2024-10-23
Recruiting
Development of Non-Invasive Prenatal Diagnosis for Single Gene Disorders
NCT06147414Invasive PreNatal Diagnosis in a Context of Family History of Single-gene Disorders, Including, Sickle Cell Disease, Cystic Fibrosis, Fragile X Syndrome
DrugBlood sample
Assistance Publique - Hôpitaux de Paris
Observational
550
Paris
2024-10-23
Active, closed
Amgen
Phase 3
19
Bordeaux, Bron, Paris
2024-10-22
Recruiting
United Pharmaceuticals
Not applicable
139
Nice, Paris, Toulon, Vincennes
2024-10-21
Recruiting
Merck Sharp & Dohme LLC
Phase 3
680
Caen, Tours, Besançon, Saint-Herblain, Lille, Lyon, Paris, Villejuif
2024-10-21
Recruiting
Janssen Research & Development, LLC
Phase 3
1,000
Avignon, Lille, Lyon, Montpellier, Nantes, Paris, Pessac, Poitiers
2024-10-18
Recruiting
Vertex Pharmaceuticals Incorporated
Phase 2
300
Clermont-Ferrand, Nîmes, Paris, Saint-Priest-en-Jarez
2024-10-18
Active, closed
Novartis Pharmaceuticals
Phase 2
251
Bron, Lille, Nice, Paris, Tours
2024-10-17
Active, closed
Streamlined Geriatric and Oncological Evaluation Based On IC Technology
NCT05720910Breast Cancer, Comorbidities and Coexisting Conditions, Lung Cancer, Colorectal Cancer
Institut Bergonié
Not applicable
720
Bayonne, Bordeaux, Dinan, La Roche-sur-Yon, Lyon, Mougins, Nice, Paris
2024-10-15
Recruiting
Study of ATX-01 in Participants With DM1
NCT06300307Myotonic Dystrophy 1
ARTHEx Biotech S.L.
Phase 1/2
56
Paris
2024-10-15
Active, closed
Evaluation of Maralixibat in Pruritus Associated With General Cholestatic Liver Disease (EXPAND)
NCT06553768Cholestatic Liver Disease (Except ALGS, PFIC, PBC and PSC)
DrugMaralixibat
Mirum Pharmaceuticals, Inc.
Phase 3
90
Marseille, Paris
2024-10-14
Recruiting
Institut Curie
Not applicable
60
Antony, Paris, Saint-Cloud, Saint-Mandé, Suresnes
2024-10-14
Recruiting
Diagnostic HER2DX-guided Treatment for Patients wIth Early-stage HER2-positive Breast Cancer
NCT06446882HER2-positive Breast Cancer, Early-stage Breast Cancer
Fundacio Clinic Barcelona
Not applicable
304
Avignon, Bordeaux, Léon, Marseille, Nancy, Paris, Toulouse
2024-10-11
Recruiting
Rennes University Hospital
Observational
80
Nîmes, Paris, Rennes, Bordeaux, Brest, Caen, Clermont-Ferrand, Créteil
2024-10-11
Active, closed
Incyte Corporation
Phase 3
349
Antony, Brest, Martigues, Mulhouse, Nantes, Paris, Romans-sur-Isère, Toulouse
2024-10-10
Active, closed
Ipsen
Phase 2
670
Amiens, Clermont-Ferrand, Nantes, Nîmes, Paris
2024-10-10
Active, closed
Mumming
Not applicable
88
Boulogne-Billancourt, Coutances, Grandchamps-des-Fontaines, Marseille, Montpellier, Paris, Ronchin, Rouen
2024-10-10
Active, closed
SynOx Therapeutics Limited
Phase 3
128
Bordeaux, Saint-Herblain, Paris, Lyon, Lille, Toulouse
2024-10-09
Active, closed
Novartis Pharmaceuticals
Phase 2
201
Dijon, Le Mans, Lille, Montpellier, Paris, Rennes, Strasbourg, Toulouse
2024-10-09
Recruiting
3D Ultrasound Myocardial Mechanical Wave Measurements
NCT06648577Chronic Primary Mitral Regurgitation
Assistance Publique - Hôpitaux de Paris
Observational
40
Paris
2024-10-09
Recruiting
Assistance Publique - Hôpitaux de Paris
Not applicable
80
Paris
2024-10-09
Recruiting
Study of the Quality of Life of Patients With Fabry Disease Aged 65 and Over With and Without Specific Treatment
NCT07277361Fabry Disease, Aged 65 Years or Older, Alpha Galactosidase A Deficiency, Galactosidase A Gene Mutation
Wladimir MAUHIN, Dr
Observational
100
Paris
2024-10-08
Active, closed
Gilead Sciences
Phase 2
268
Bobigny, Marseille, Nice, Paris
2024-10-07
Recruiting
Amivas Inc.
Observational
15
Paris
2024-10-06
Recruiting
Efficacy of INM004 in Children With STEC-HUS
NCT06389474Hemolytic-Uremic Syndrome
Inmunova S.A.
Phase 3
220
Bordeaux, Lyon, Montpellier, Nantes, Paris, Rouen
2024-10-05
Recruiting
Centre Hospitalier St Anne
Not applicable
200
Paris
2024-10-04
Active, closed
AstraZeneca
Phase 3
768
Bordeaux, Caen, Lille, Montpellier, Nantes, Paris, Pessac, Toulon Armees
2024-10-04
Recruiting
Rhu-pGSN for Acute Respiratory Distress Syndrome (ARDS)
NCT05947955Acute Respiratory Distress Syndrome, Infections
BioAegis Therapeutics Inc.
Phase 2
600
La Roche-sur-Yon, Le Kremlin-Bicêtre, Melun, Nantes, Oullins-Pierre-Bénite, Paris, Strasbourg
2024-10-03
Recruiting
SoniVie Inc.
Not applicable
261
Bordeaux, Paris
2024-10-03
Recruiting
Ajax Therapeutics, Inc., a wholly owned subsidiary of Eli Lilly and Company
Phase 1
256
Paris
2024-10-03
Active, closed
Teva Branded Pharmaceutical Products R&D LLC
Phase 2
349
Bordeaux, Caen, Marseille, Paris, Toulouse
2024-10-02
Recruiting
Fondation Ophtalmologique Adolphe de Rothschild
Not applicable
15
Paris
2024-10-02
Recruiting
Ferring Pharmaceuticals
Phase 3
250
Clermont-Ferrand, Lyon, Toulouse, Nantes, Bordeaux, Nîmes, Paris
2024-10-01
Not yet open
Centre Hospitalier Universitaire de Nīmes
Observational
10,000
Nîmes, Paris
2024-10-01
Recruiting
Ferring Pharmaceuticals
Phase 3
454
Clermont-Ferrand, Toulouse, Nantes, Bordeaux, Rouen, Nîmes, Lyon, Paris
2024-10-01
Recruiting
Assistance Publique - Hôpitaux de Paris
Observational
100,000
Paris
2024-10-01
Recruiting
Functional Impairment in Albinism
NCT06345976Albinism, Ocular
Fondation Ophtalmologique Adolphe de Rothschild
Observational
50
Paris
2024-10-01
Recruiting
Institut Mutualiste Montsouris
Not applicable
90
Paris
2024-10
Recruiting
Dexamethasone and Pregnancy: Maternal Effects
NCT06259994Dexamethasone During Pregnancy
Assistance Publique - Hôpitaux de Paris
Observational
35
Bordeaux, Bron, Grenoble, Le Kremlin-Bicêtre, Lille, Nantes, Paris, Toulouse
2024-09-30
Recruiting
Institut Pasteur
Not applicable
38
Paris
2024-09-30
Recruiting
AstraZeneca
Observational
24,000
Paris
2024-09-30
Recruiting
Assistance Publique - Hôpitaux de Paris
Phase 3
130
Paris
2024-09-30
By invitation
Open-Label Extension Study to Assess GLM101 in PMM2-CDG Patients
NCT06657859Pmm2-CDG, Phosphomannomutase 2 Deficiency
Glycomine, Inc.
Phase 2
90
Paris
2024-09-30
Recruiting
Egle Therapeutics
Phase 1/2
50
Dijon, Montpellier, Paris
2024-09-27
Recruiting
BioCryst Pharmaceuticals
Phase 1
78
Paris
2024-09-26
Active, closed
Longboard Pharmaceuticals
Phase 3
96
Lille, Toulouse, Bron, Marseille, Paris, Strasbourg, Villejuif
2024-09-25
Active, closed
Merus B.V.
Phase 3
699
Bordeaux, Le Mans, Lille, Lyon, Marseille, Montpellier, Nice, Paris
2024-09-25
Recruiting
Hospices Civils de Lyon
Observational
50
Amiens, Bron, Clermont-Ferrand, Creil, Dijon, Lyon, Paris, Pierre-Bénite
2024-09-24
Recruiting
Assistance Publique - Hôpitaux de Paris
Observational
250
Paris
2024-09-24
Recruiting
Hospices Civils de Lyon
Phase 2
25
Bron, Paris
2024-09-24
Active, closed
argenx
Phase 1
15
Marseille, Paris
2024-09-24
Active, closed
A Study to Evaluate the Efficacy and Safety of Sotagliflozin in Symptomatic Obstructive and Non-obstructive Hypertrophic Cardiomyopathy
NCT06481891Obstructive Cardiomyopathy, Hypertrophic, Non-obstructive Hypertrophic Cardiomyopathy
DrugSotagliflozin
Lexicon Pharmaceuticals
Phase 3
500
Chambray-lès-Tours, Marseille, Paris, Poitiers, Rennes, Toulouse
2024-09-24
Active, closed
Hoffmann-La Roche
Phase 3
338
Brest, Bron, Lille, Lyon, Montpellier, Nice, Paris, Pessac
2024-09-23
Recruiting
Assistance Publique - Hôpitaux de Paris
Not applicable
44
Paris
2024-09-23
Recruiting
Rennes University Hospital
Not applicable
1,680
Lille, Limoges, Paris, Pierre-Bénite, Plérin, Rennes, Rouen, Saint-Etienne
2024-09-23
Recruiting
Merck Sharp & Dohme LLC
Phase 1/2
160
Brest, Lille, Paris
2024-09-20
Recruiting
Assistance Publique - Hôpitaux de Paris
Observational
175
Paris
2024-09-19
Recruiting
A Study of LY4050784 in Participants With Advanced or Metastatic Solid Tumors
NCT06561685Metastatic Solid Tumor, Advanced Solid Tumor, Non-small Cell Lung Cancer, SMARCA4-Deficient Tumor
DrugsNab-paclitaxel·Pemetrexed·Paclitaxel·Cisplatin
Eli Lilly and Company
Phase 1
340
Bordeaux, Paris, Villejuif
2024-09-19
Active, closed
argenx
Phase 3
141
Paris
2024-09-18
Recruiting
Centre Hospitalier St Anne
Not applicable
250
Grenoble, Paris
2024-09-18
Recruiting
European Registry of Next Generation Imaging in Advanced Prostate Cancer
NCT06866782Prostate Cancer, Advanced Prostate Cancer, Metastatic Prostate Cancer (mPC)
Fundacio Puigvert
Observational
600
Lille, Lyon, Paris
2024-09-17
Recruiting
University Hospital, Limoges
Not applicable
1,000
Lille, Limoges, Marseille, Montpellier, Nice, Paris, Tours
2024-09-17
Active, closed
Novo Nordisk A/S
Phase 4
500
Lille, Nice, Paris, Rouen, Toulouse
2024-09-17
Active, closed
Dianthus Therapeutics
Phase 2
46
Marseille, Paris
2024-09-17
Active, closed
GlaxoSmithKline
Phase 2
153
Marseille, Melun, Montpellier, Nantes, Paris
2024-09-17
Recruiting
Assistance Publique - Hôpitaux de Paris
Observational
40
Paris
2024-09-16
Recruiting
Regeneron Pharmaceuticals
Phase 2
116
Poitiers, Paris
2024-09-16
Recruiting
Analysis of Parental Support in Families Using the LENA After Early Cochlear Implantation
NCT05917496Profound Congenital Deafness, Cochlear Implantation
Assistance Publique - Hôpitaux de Paris
Observational
30
Paris
2024-09-13
Active, closed
Pharmacokinetic Similarity Between ABP 234 and Keytruda® (Pembrolizumab)
NCT06430866Early-stage Non-squamous Non-small Cell Lung Cancer (NSCLC)
DrugsABP 234·Pembrolizumab
Amgen
Phase 3
163
Bayonne, Bordeaux, Caen, Marseille, Paris, Toulon, Vantoux
2024-09-12
Active, closed
Centre Leon Berard
Not applicable
240
Lyon, Montpellier, Paris, Saint-Cloud, Vandœuvre-lès-Nancy, Villejuif
2024-09-12
Recruiting
Regeneron Pharmaceuticals
Phase 1/2
130
Bron, Lille, Paris
2024-09-11
Recruiting
Diagnostic Evaluation of Dementia with Lewy Bodies Using a Multimodal Approach
NCT06068361Lewy Bodies Disease, Alzheimer Disease, Cognitive Impairment
Assistance Publique - Hôpitaux de Paris
Observational
130
Paris
2024-09-11
Active, closed
GCP-Service International West GmbH
Phase 2
41
Grenoble, Nice, Paris, Pessac, Toulouse
2024-09-10
Active, closed
Evaluation of the Effect of Lomitapide Treatment on Major Adverse Cardiovascular Events (MACE) in Patients With Homozygous Familial Hypercholesterolemia
NCT06832371Homozygous Familial Hypercholesterolemia (HoFH), Major Adverse Cardiovascular Events (MACE), Dyslipidemia
Fondazione SISA (Societa Italiana per lo Studio della Arteriosclerosi)
Observational
73
Lille, Lyon, Marseille, Paris, Strasbourg
2024-09-09
Recruiting
Safety and Effectiveness of Mechanical Thrombectomy Using the Anaconda ANA Funnel Catheter
NCT06370182Acute Ischemic Stroke From Large Vessel Occlusion
Anaconda Biomed S.L.
Not applicable
327
Montpellier, Paris, Suresnes, Toulouse
2024-09-09
Recruiting
Fondation Ophtalmologique Adolphe de Rothschild
Observational
1,000
Paris
2024-09-09
Recruiting
Australia and New Zealand Sarcoma Association
Observational
100
Paris
2024-09-05
Active, closed
Novartis Pharmaceuticals
Phase 2
179
Bordeaux, Clermont-Ferrand, Marseille, Montpellier, Nantes, Paris, Strasbourg, Toulouse
2024-09-04
Recruiting
ATLAS (AltaValve) Pivotal Trial
NCT06465745Mitral Regurgitation, Mitral Insufficiency, Mitral Valve Incompetence, Mitral Valve Regurgitation
4C Medical Technologies, Inc.
Not applicable
450
Bordeaux, Marseille, Paris, Toulouse
2024-09-03
Recruiting
Detection of Plasma DNA of Renal Origin in Kidney Transplant Patients
NCT06026592Acute Kidney Injury, Renal Transplantation
Assistance Publique - Hôpitaux de Paris
Observational
30
Paris
2024-09-02
Not yet open
Pharmacokinetics and Modelling of Beta-Lactam in ECMO-VA Patients
NCT06338345Cardiogenic Shock, Post-cardiac Surgery, Cardiac Arrest, Extracorporeal Membrane Oxygenation Complication
University Hospital, Grenoble
Not applicable
225
Clermont-Ferrand, Dijon, Paris, Rouen, Toulouse
2024-09-01
Not yet open
Paris Brain Institute (ICM)
Observational
1,000
Paris
2024-09-01
Not yet open
Hospices Civils de Lyon
Phase 2
70
Bordeaux, Bron, Clermont-Ferrand, Grenoble, Lille, Lyon, Paris, Pierre-Bénite
2024-09-01
Not yet open
University Hospital, Toulouse
Phase 2
26
Paris, Toulouse
2024-09
Active, closed
Celgene
Phase 2
95
Saint-Cloud, Lille, Poitiers, Paris
2024-08-30
Active, closed
Alpine Immune Sciences Inc, A Subsidiary of Vertex
Phase 3
605
Bordeaux, Créteil, Le Puy-en-Velay, Marseille, Nantes, Paris, Saint-Priest-en-Jarez, Valenciennes
2024-08-30
Active, closed
Sanofi
Phase 2
229
Nice, Paris
2024-08-29
Active, closed
Gilead Sciences
Phase 3
640
Caen, Marseille, Nice, Paris, Pierre-Bénite, Saint-Herblain, Vandœuvre-lès-Nancy, Villejuif
2024-08-28
Active, closed
Assistance Publique - Hôpitaux de Paris
Not applicable
90
Paris
2024-08-27
Recruiting
Study of the Pathophysiology of RNU4ATAC and RTTN Associated Syndromes
NCT06111950Taybi Linder Syndrome, Microcephalic Osteodysplastic Primordial Dwarfism Types I and III, Roifman Syndrome, Lowry Wood Syndrome
Hospices Civils de Lyon
Not applicable
45
Bordeaux, Bron, Dijon, Lille, Paris, Rennes
2024-08-27
Recruiting
Assistance Publique - Hôpitaux de Paris
Not applicable
72
Bobigny, Créteil, Paris
2024-08-27
Recruiting
Observational Study of Venus P-Valve
NCT05835349Right Ventricular Outflow Tract Dysfunction
Venus MedTech (HangZhou) Inc.
Observational
200
Pessac, Nantes, Le Plessis-Robinson, Paris
2024-08-26
Recruiting
Rapid Molecular Diagnosis and Detection of Emerging Infectious Diseases in Patients With Tropical Fever (Tropifever)
NCT06539325Infectious Diseases in Febrile Patients Returning From Tropical Countries
Assistance Publique - Hôpitaux de Paris
Not applicable
564
Paris
2024-08-26
Active, closed
Kite, A Gilead Company
Phase 3
452
Lille, Marseille, Montpellier, Nantes, Paris, Pierre-Bénite, Poitiers, Rennes
2024-08-23
Recruiting
Sanofi
Phase 3
160
Le Kremlin-Bicêtre, Lille, Marseille, Nice, Paris
2024-08-21
Recruiting
Assistance Publique - Hôpitaux de Paris
Observational
319
Paris
2024-08-21
Recruiting
Assistance Publique - Hôpitaux de Paris
Observational
200
Paris
2024-08-21
Recruiting
Hopital Foch
Phase 3
120
Paris, Suresnes
2024-08-20
Recruiting
Phase 1b Trial of RAY121 in Immunological Diseases (RAINBOW Trial)
NCT06371417Antiphospholipid Syndrome (APS), Bullous Pemphigoid (BP), Behçet's Syndrome (BS), Dermatomyositis (DM)
DrugRAY121
Chugai Pharmaceutical
Phase 1
144
Montpellier, Paris
2024-08-19
Active, closed
AbbVie
Phase 3
699
Toulouse, Vandœuvre-lès-Nancy, Bordeaux, Nantes, Clermont-Ferrand, Amiens, Paris, Argenteuil
2024-08-19
Recruiting
Assistance Publique - Hôpitaux de Paris
Phase 3
80
Paris
2024-08-14
Recruiting
Institut du Cancer de Montpellier - Val d'Aurelle
Not applicable
264
Saint-Herblain, Vandœuvre-lès-Nancy, Lyon, Montpellier, Nice, Nîmes, Paris, Toulouse
2024-08-09
Active, closed
AbbVie
Phase 3
111
Caen, Bron, Paris
2024-08-08
Active, closed
Incyte Corporation
Phase 1
37
Paris, Villejuif
2024-08-08
Recruiting
Substudy 06D: Combination Therapies in Second Line (2L) Gastroesophageal Adenocarcinoma (MK-3475-06D/Keymaker-U06)
NCT06445972Gastroesophageal Junction, Gastroesophageal Adenocarcinoma, Esophageal Neoplasms, Esophageal Cancer
DrugsPatritumab deruxtecan·Ramucirumab·Sacituzumab tirumotecan·Paclitaxel
Merck Sharp & Dohme LLC
Phase 1/2
210
Brest, Lille, Paris
2024-08-07
Active, closed
EyeBiotech Ltd.
Phase 2/3
984
Dijon, Créteil, Lyon, Marseille, Paris, Saint-Cyr-sur-Loire
2024-08-07
Recruiting
Centre Hospitalier Universitaire de Nice
Phase 2
20
Nice, Paris, Toulouse
2024-08-06
Active, closed
Iptacopan in Patients With ANCA Associated Vasculitis
NCT06388941Anti-Neutrophil Cytoplasm Antibodies (ANCA) Associated Vasculitis
DrugsIptacopan·Rituximab
Novartis Pharmaceuticals
Phase 2
84
Angers, Brest, Dijon, Marseille, Paris, Toulouse
2024-08-05
Recruiting
AbbVie
Phase 3
170
Metz, Créteil, Paris, St-Priest-en-Jarez, Nice, Bayonne, Chambéry, Amiens
2024-08-05
Recruiting
AstraZeneca
Phase 3
788
Angers, Besançon, Lille, Lyon, Marseille, Paris, Rouen, Saint-Herblain
2024-08-01
Recruiting
Assistance Publique - Hôpitaux de Paris
Observational
200
Paris
2024-08-01
Recruiting
Lallemand Health Solutions
Phase 2
70
Bécon-les-Granits, Boulogne-sur-Mer, Caen, La Tronche, Lille, Montauban, Nantes, Paris
2024-08
Active, closed
Ultragenyx Pharmaceutical Inc
Phase 3
255
Marseille, Paris
2024-07-31
Active, closed
Novartis Pharmaceuticals
Phase 3
146
Limoges, Garches, Nice, Paris
2024-07-31
Recruiting
Fondation Ophtalmologique Adolphe de Rothschild
Observational
196
Paris
2024-07-31
By invitation
AOP Orphan Pharmaceuticals AG
Observational
110
Paris, Strasbourg
2024-07-31
Recruiting
AOP Orphan Pharmaceuticals AG
Phase 3
20
Paris
2024-07-31
Recruiting
NovoCure GmbH
Phase 3
734
Créteil, Limoges, Marseille, Nantes, Paris, Pessac, Pierre-Bénite, Strasbourg
2024-07-31
Recruiting
Institut National de la Santé Et de la Recherche Médicale, France
Observational
250
Paris
2024-07-31
Recruiting
University Medical Center Groningen
Phase 3
300
Bordeaux, Brest, Lyon, Nancy, Paris
2024-07-31
Active, closed
Annexon, Inc.
Phase 3
659
Bordeaux, Créteil, Dijon, Écully, Marseille, Nice, Paris, Strasbourg
2024-07-30
Active, closed
AbbVie
Phase 2
108
Marseille, Tours, Paris, Pierre-Bénite, Le Mans
2024-07-29
Recruiting
Assistance Publique - Hôpitaux de Paris
Observational
194
Paris
2024-07-29
Recruiting
Hospices Civils de Lyon
Not applicable
60
Bron, Brest, Garche, Lille, Marseille, Paris, Strasbourg, Toulouse
2024-07-24
Recruiting
PulseSelect™ PFA Global Registry
NCT06393920Atrial Fibrillation
Medtronic Cardiac Ablation Solutions
Observational
1,950
Grenoble, Le Coudray, Massy, Paris, Toulouse
2024-07-23
Active, closed
Ferrer Internacional S.A.
Phase 2
241
Bordeaux, Marseille, Nîmes, Paris, Toulouse
2024-07-23
Recruiting
Daiichi Sankyo
Phase 1/2
123
Lille, Lyon, Marseille, Paris, Rennes, Saint-Herblain, Suresnes, Villejuif
2024-07-22
Active, closed
MedSIR
Phase 2
165
Marseille, Paris
2024-07-22
Active, closed
Janssen Pharmaceutica N.V., Belgium
Phase 2
55
Lille, Nantes, Paris, Toulouse, Tours
2024-07-22
Recruiting
Centre Hospitalier St Anne
Not applicable
25
Paris
2024-07-19
Recruiting
Assistance Publique - Hôpitaux de Paris
Observational
1,400
Paris
2024-07-19
Recruiting
Neuro-computational Study of Thymic Fluctuations in Mood Disorders
NCT07033923Depression, Bipolar Disorder, Recurrent Depression, Mood Disorders
Centre Hospitalier St Anne
Not applicable
588
Paris
2024-07-18
Recruiting
Assistance Publique - Hôpitaux de Paris
Not applicable
180
Clichy, Nantes, Paris
2024-07-18
Recruiting
Bristol-Myers Squibb
Phase 1/2
224
Créteil, Marseille, Paris, Strasbourg
2024-07-17
Recruiting
Amgen
Phase 3
450
Clermont-Ferrand, Créteil, Dijon, Lyon, Montpellier, Nice, Paris, Pessac
2024-07-17
Recruiting
Heidelberg University
Observational
4,000
Paris
2024-07-16
Recruiting
Assistance Publique - Hôpitaux de Paris
Phase 3
300
Bron, Paris
2024-07-16
Active, closed
Cardiovascular and Interventional Radiological Society of Europe
Observational
400
Dijon, Paris, Strasbourg
2024-07-15
Recruiting
COmbined pLaTelet and eRythrocyte AutotransfusioN During Cardiac surgEry (COLTRANE) Trial
NCT06425614On-pump Cardiac Surgery, High Risk for Bleeding, Autotransfusion
University Hospital, Bordeaux
Not applicable
570
Bordeaux, Bron, Montpellier, Nantes, Paris, Rennes, Strasbourg, Toulouse
2024-07-15
Active, closed
A Study to Test the Effects and Safety of Riliprubart in People With Chronic Inflammatory Demyelinating Polyneuropathy (CIDP) for Which the Usual Treatments do Not Work
NCT06290128Chronic Inflammatory Demyelinating Polyradiculoneuropathy, Polyneuropathy, Inflammatory Demyelinating, Chronic
DrugRiliprubart
Sanofi
Phase 3
109
Le Kremlin-Bicêtre, Lille, Marseille, Montpellier, Paris
2024-07-12
Recruiting
Centre Hospitalier St Anne
Observational
128
Paris
2024-07-12
Recruiting
Replimune, Inc.
Phase 3
400
Bordeaux, Lille, Marseille, Nice, Paris, Pierre-Bénite, Villejuif
2024-07-11
Active, closed
Celldex Therapeutics
Phase 3
963
Pierre-Bénite, La Tronche, Martigues, Nantes, Nice, Paris, Rouen
2024-07-11
Recruiting
Marc Donath
Phase 2
300
Paris
2024-07-09
Recruiting
Ivosidenib in Participants With Locally Advanced or Metastatic Conventional Chondrosarcoma Untreated or Previously Treated With 1 Systemic Treatment Regimen
NCT06127407Locally Advanced or Metastatic Conventional Chondrosarcoma With an IDH1 Mutation, Untreated or Previously Treated With 1 Systemic Treatment Regimen
DrugIvosidenib
Servier Bio-Innovation LLC
Phase 3
136
Bordeaux, Lille, Lyon, Marseille, Paris, Saint-Herblain, Strasbourg, Toulouse
2024-07-09
Recruiting
Assistance Publique - Hôpitaux de Paris
Not applicable
400
Paris
2024-07-08
Recruiting
Fundacion Oncosur
Phase 2
78
Bordeaux, Brest, Lille, Paris, Strasbourg, Villejuif
2024-07-05
Recruiting
Gérond'if
Observational
637
Paris, Nantes, Poitiers, Rouen, Montpellier, Toulouse, Amiens, Angers
2024-07-01
Active, closed
AstraZeneca
Phase 3
339
Bois-Guillaume, Dijon, Lyon, Montivilliers, Nantes, Paris, Poitiers, Toulouse
2024-06-29
Recruiting
Boehringer Ingelheim
Phase 1/2
768
Bordeaux, Caen, Lyon, Marseille, Paris, Rennes, Saint-Herblain, Strasbourg
2024-06-28
Active, closed
AbbVie
Phase 3
1,400
Lyon, St-Priest-en-Jarez, Martigues, Rouen, Paris, Reims
2024-06-27
Recruiting
Assistance Publique - Hôpitaux de Paris
Phase 2
68
Clamart, Clichy, Paris
2024-06-25
Recruiting
Assistance Publique - Hôpitaux de Paris
Phase 3
60
Paris, Le Kremlin-Bicêtre
2024-06-25
Recruiting
Merck Healthcare KGaA, Darmstadt, Germany, an affiliate of Merck KGaA, Darmstadt, Germany
Phase 3
264
Nice, Strasbourg, La Tronche, Paris, Clermont-Ferrand, Bron, Créteil
2024-06-25
Recruiting
Fondation Hôpital Saint-Joseph
Not applicable
100
Paris
2024-06-24
Recruiting
Peripheral Tissue Perfusion in Intensive Care
NCT06384287Acute Circulatory Failure
Assistance Publique - Hôpitaux de Paris
Observational
180
Paris
2024-06-22
Active, closed
Sensorion
Phase 1/2
12
Paris
2024-06-21
Recruiting
Medtronic - MITG
Not applicable
278
Paris
2024-06-21
Recruiting
AstraZeneca
Phase 3
240
Angers, Brest, Le Mans, Lille, Lyon, Paris, Reims, Rouen
2024-06-20
Recruiting
Direction Centrale du Service de Santé des Armées
Observational
540
Paris
2024-06-19
Recruiting
Assistance Publique - Hôpitaux de Paris
Observational
100
Paris
2024-06-19
Active, closed
Ivy Brain Tumor Center
Phase 3
450
Nice, Marseille, Montpellier, Rennes, Saint-Herblain, Paris, Bron, Lyon
2024-06-19
Recruiting
Assistance Publique - Hôpitaux de Paris
Phase 3
2,468
Paris
2024-06-18
Recruiting
Nutricia Nutrition Clinique
Observational
3,000
Nice, Paris
2024-06-17
Active, closed
BioMarin Pharmaceutical
Phase 3
80
Lyon, Marseille, Paris, Toulouse
2024-06-17
Not yet open
Assistance Publique - Hôpitaux de Paris
Observational
500
Paris
2024-06-15
Active, closed
Extended Validation of Donor-derived Cell-free DNA in Kidney Transplant Recipients
NCT07805343Rejection Acute Renal, Rejection Chronic Renal, Transplantation, Kidney Rejection Transplant
Paris Translational Research Center for Organ Transplantation
Observational
5,000
Paris, Toulouse
2024-06-15
Recruiting
Golcadomide Post-CAR T-cell in R/R Aggressive Large B-cell Lymphoma Patients With High Risk of Relapse
NCT06271057Diffuse Large B-cell Lymphoma Refractory, Refractory Primary Mediastinal Large B-Cell Lymphoma, Refractory Transformed B-cell Non-Hodgkin Lymphoma, Refractory High Grade B-Cell Lymphoma
DrugGolcadomide
The Lymphoma Academic Research Organisation
Phase 2
65
Créteil, Dijon, La Tronche, Lille, Marseille, Montpellier, Nantes, Paris
2024-06-14
Active, closed
Merck Sharp & Dohme LLC
Phase 3
550
Strasbourg, Marseille, Paris, Villejuif
2024-06-11
Recruiting
University Hospital, Brest
Not applicable
665
Amiens, Angers, Brest, Colombes, La Roche-sur-Yon, Le Kremlin-Bicêtre, Les Sables-d'Olonne, Paris
2024-06-11
Recruiting
Merck Sharp & Dohme LLC
Phase 3
851
Marseille, Vantoux, Angers, Avignon, La Roche-sur-Yon, Paris
2024-06-10
Recruiting
Centre Francois Baclesse
Not applicable
268
Besançon, Caen, Clermont-Ferrand, Lyon, Paris, Plérin, Saint-Cloud, Saint-Etienne
2024-06-07
Recruiting
MabQuest SA
Phase 1
30
Lyon, Paris, Rennes, Toulouse
2024-06-06
Recruiting
X4 Pharmaceuticals
Phase 3
176
Lyon, Paris, Rennes, Toulouse
2024-06-06
Recruiting
QED Therapeutics, a BridgeBio company
Observational
150
Bron, Paris, Toulouse
2024-06-05
Recruiting
ANRS, Emerging Infectious Diseases
Phase 3
524
Paris
2024-06-05
Active, closed
Amgen
Phase 3
563
Bordeaux, Brest, Créteil, Le Mans, Lyon, Marseille, Montpellier, Paris
2024-06-05
Recruiting
Assistance Publique - Hôpitaux de Paris
Phase 3
50
Paris
2024-06-04
Recruiting
University Hospital, Bordeaux
Not applicable
192
Paris, Montpellier, Palavas-les-Flots, Pessac
2024-06-03
Recruiting
Eli Lilly and Company
Phase 3
300
Angers, Bron, Lille, Marseille, Paris, Toulouse
2024-06-03
Recruiting
Kartos Therapeutics, Inc.
Phase 3
600
Paris, Amiens, Angers, Lille, Lyon, Nantes, Nice, Nîmes
2024-06-03
Recruiting
Institut Pasteur
Observational
200
Paris
2024-06-01
Not yet open
Assistance Publique - Hôpitaux de Paris
Phase 2
20
Paris
2024-06
Recruiting
Assistance Publique - Hôpitaux de Paris
Not applicable
56
Paris
2024-05-31
Recruiting
Assistance Publique - Hôpitaux de Paris
Phase 2
139
Paris
2024-05-31
Active, closed
Janssen Research & Development, LLC
Phase 2
333
Clermont-Ferrand, Nantes, Paris, Pierre-Bénite, Reims, Strasbourg
2024-05-30
Active, closed
Amgen
Phase 1/2
94
Nantes, Paris
2024-05-30
Recruiting
University Hospital, Montpellier
Not applicable
112
Angers, Montpellier, Paris, Tours
2024-05-29
Recruiting
Assistance Publique - Hôpitaux de Paris
Not applicable
836
Paris
2024-05-27
Recruiting
ANRS, Emerging Infectious Diseases
Phase 1/2
215
Créteil, Paris
2024-05-27
Recruiting
A Study to Evaluate the Efficacy and Safety of Pegozafermin in Participants With Compensated Cirrhosis Due to MASH
NCT06419374Metabolic Dysfunction-Associated Steatohepatitis (MASH) / Nonalcoholic Steatohepatitis (NASH) With Compensated Cirrhosis
DrugPegozafermin
Hoffmann-La Roche
Phase 3
1,800
Amiens, Clichy, Dijon, Limoges, Lyon, Montpellier, Nice, Paris
2024-05-24
Active, closed
International Extranodal Lymphoma Study Group (IELSG)
Phase 3
122
Bordeaux, Grenoble, Paris, Pierre-Bénite, Vandœuvre-lès-Nancy
2024-05-21
Recruiting
Novartis Pharmaceuticals
Phase 3
550
Montpellier, Paris, Toulouse
2024-05-21
Recruiting
Centre Hospitalier St Anne
Not applicable
20
Paris
2024-05-21
Recruiting
VE303 for Prevention of Recurrent Clostridioides Difficile Infection
NCT06237452Clostridium Difficile, Clostridium Difficile Infections, Clostridium Difficile Infection Recurrence, Clostridioides Difficile Infection
Vedanta Biosciences, Inc.
Phase 3
852
Les Paris, Dijon, Paris, Bordeaux Cedex, Garches, Nantes, Lyon, Tours
2024-05-20
Recruiting
Drugs Experience for Adolescents With Anorexia
NCT06211517Anorexia Nervosa, Psychotropic Drugs, Adolescent
Assistance Publique - Hôpitaux de Paris
Observational
90
Paris
2024-05-20
Recruiting
Merck Sharp & Dohme LLC
Phase 1/2
220
Bordeaux, Strasbourg, Paris, Villejuif
2024-05-20
Recruiting
University Hospital, Angers
Not applicable
120
Angers, Lille, Lyon, Marseille, Nancy, Paris, Rennes
2024-05-15
Recruiting
Assistance Publique - Hôpitaux de Paris
Observational
385
Paris
2024-05-15
Recruiting
Institut National de la Santé Et de la Recherche Médicale, France
Phase 1
39
Paris
2024-05-14
Recruiting
Assistance Publique - Hôpitaux de Paris
Observational
500
Paris
2024-05-14
Recruiting
Belief Updating in Treatment Resistant Depression
NCT05577247Treatment Resistant Depression
Assistance Publique - Hôpitaux de Paris
Observational
60
Paris
2024-05-13
Recruiting
Hopital Foch
Phase 2
640
Suresnes, Bron, Marseille, Paris
2024-05-10
Active, closed
Sanofi
Phase 3
1,541
Antony, Nice, Paris, Pierre-Bénite, Reims, Romans-sur-Isère, Rouen, Toulouse
2024-05-08
Recruiting
Hospices Civils de Lyon
Phase 1/2
56
Annecy, Clermont-Ferrand, Grenoble, Lille, Lyon, Marseille, Paris, Saint-Etienne
2024-05-07
Recruiting
Assistance Publique - Hôpitaux de Paris
Observational
80
Paris
2024-05-07
Active, closed
Centre Hospitalier Universitaire de Nice
Phase 2
128
Nice, Paris, Bordeaux, Lille, Lyon
2024-05-05
Active, closed
Merck Sharp & Dohme LLC
Phase 3
473
Bordeaux, Lyon, Caen, Toulouse, Lille, Rennes, Poitiers, Paris
2024-05-03
Active, closed
Hoffmann-La Roche
Phase 2
256
Bron, Lille, Marseille, Paris, Rouen, Saint-Herblain, Strasbourg, Toulouse
2024-05-02
Active, closed
SOTIO Biotech AG
Phase 1
40
Paris
2024-05-01
Recruiting
Enhanced Valves Interventions and Safe AI Generated End Results
NCT07213531Heart Valve Disease, TAVI, M-TEER, TTVI
Montreal Heart Institute
Observational
21,000
Bourdeaux, Lille, Marseille, Paris, Rennes, Toulouse
2024-05-01
Recruiting
Assistance Publique - Hôpitaux de Paris
Observational
396
Paris
2024-05
Not yet open
University Hospital, Toulouse
Not applicable
150
Bordeaux, Limoges, Montpellier, Paris, Toulouse
2024-05
By invitation
Travere Therapeutics, Inc.
Phase 3
100
Paris, Tours, Vandœuvre-lès-Nancy
2024-04-30
Active, closed
Erasca, Inc.
Phase 3
78
Bordeaux, Dijon, Le Mans, Lille, Lyon, Marseille, Paris, Villejuif
2024-04-29
Recruiting
AstraZeneca
Phase 3
582
Angers, Marseille, Paris, Strasbourg
2024-04-29
Recruiting
Study of REM-422 in Patients With AML or Higher Risk MDS
NCT06297941Myelodysplastic Syndromes, Higher Risk Myelodysplastic Syndromes, Acute Myeloid Leukemia, Acute Myeloid Leukemia Refractory
DrugREM-422
Remix Therapeutics
Phase 1
100
Bordeaux, Paris, Toulouse, Villejuif
2024-04-26
Active, closed
Alnylam Pharmaceuticals
Observational
346
Paris
2024-04-25
Recruiting
Centre de Recherches et d'Etude sur la Pathologie Tropicale et le Sida
Observational
120
Paris
2024-04-23
By invitation
ACADIA Pharmaceuticals Inc.
Phase 3
752
Paris, Toulouse
2024-04-23
Active, closed
Amgen
Phase 3
111
Bordeaux, Lille, Paris
2024-04-22
Recruiting
Karyopharm Therapeutics Inc
Phase 2
58
Bordeaux, Pierre-Bénite, Tours, Nîmes, Angers, Paris, Saint-Priest-en-Jarez
2024-04-22
Recruiting
Janssen Research & Development, LLC
Phase 1/2
287
Avignon, Lille, Nantes, Paris, Villejuif
2024-04-22
Recruiting
Assistance Publique - Hôpitaux de Paris
Not applicable
60
Paris
2024-04-19
Recruiting
Janssen Research & Development, LLC
Phase 3
641
Lille, Limoges, Lyon, Marseille, Paris, Quint-Fonsegrives, Rennes, Toulouse
2024-04-18
Recruiting
PERROD Guillaume
Not applicable
272
Paris
2024-04-18
Active, closed
Bristol-Myers Squibb
Phase 3
44
Paris, Pessac
2024-04-17
Active, closed
Janssen-Cilag Ltd.
Phase 3
120
Amiens, Clermont-Ferrand, Lille, Marseille, Nantes, Paris
2024-04-17
Recruiting
Assistance Publique - Hôpitaux de Paris
Not applicable
160
Paris
2024-04-17
Active, closed
argenx
Phase 3
119
Marseille, Nice, Paris
2024-04-16
Recruiting
Assistance Publique - Hôpitaux de Paris
Observational
330
Paris
2024-04-15
Recruiting
Management of Malignant Gastric Outlet Obstruction Between Surgery and Endoscopy
NCT06071507Gastric Outlet Obstruction, Pancreatic Cancer
IRCCS San Raffaele
Observational
250
Paris
2024-04-15
Recruiting
Merck Sharp & Dohme LLC
Phase 3
1,200
Lyon, Caen, Montpellier, Nantes, Poitiers, Paris
2024-04-14
Recruiting
ANRS, Emerging Infectious Diseases
Phase 2
69
Bobigny, Clamart, Clichy, Créteil, Garches, Le Kremlin-Bicêtre, Paris, Suresnes
2024-04-11
Active, closed
Merck Sharp & Dohme LLC
Phase 2
272
Lyon Cedex08, Besançon, Toulouse, Paris, Villejuif
2024-04-10
Recruiting
Daiichi Sankyo
Phase 1/2
680
Dijon, Bordeaux, Montpellier, Rennes, Saint-Herblain, Paris, Lyon, Villejuif
2024-04-10
Active, closed
AbbVie
Phase 2/3
167
Marseille, La Tronche, Paris, Bron, Créteil
2024-04-10
Recruiting
McGill University Health Centre/Research Institute of the McGill University Health Centre
Not applicable
110
Paris
2024-04-09
Active, closed
Janssen Research & Development, LLC
Phase 3
272
Lille, Limoges, Marseille, Paris, Quint-Fonsegrives, Rennes, Suresnes
2024-04-09
Active, closed
Amgen
Phase 3
434
Bordeaux, Brest, Mulhouse, Paris, Strasbourg
2024-04-08
Recruiting
Assistance Publique - Hôpitaux de Paris
Phase 2
210
Créteil, Clamart, Clermont-Ferrand, Colombes, Bobigny, Paris, Sevran, Montpellier
2024-04-08
Active, closed
Shape Memory Medical, Inc.
Not applicable
180
Lille, Paris
2024-04-05
Recruiting
Assistance Publique - Hôpitaux de Paris
Not applicable
50
Paris
2024-04-04
Recruiting
Study of the Prevalence of Endometriosis and Adenomyosis
NCT06211569Elective Fertility Preservation
Assistance Publique - Hôpitaux de Paris
Observational
400
Paris
2024-04-04
Recruiting
Assistance Publique - Hôpitaux de Paris
Not applicable
35
Paris
2024-04-04
Active, closed
Novartis Pharmaceuticals
Phase 2
23
Paris, Vandœuvre-lès-Nancy
2024-04-04
Recruiting
Assistance Publique - Hôpitaux de Paris
Not applicable
40
Angers, Le Kremlin-Bicêtre, Lyon, Paris, Poitiers
2024-04-04
Active, closed
A Study Evaluating the Safety and Efficacy of Inhaled AP01 in Participants With Progressive Pulmonary Fibrosis
NCT06329401Pulmonary Fibrosis, Progressive Pulmonary Fibrosis, Pulmonary Fibrosis Secondary to Systemic Sclerosis, Pulmonary Fibrosis, Interstitial Lung Disease
DrugPirfenidone
Avalyn Pharma Inc.
Phase 2
398
Rennes, Tours, Metz, Lyon, Montpellier, Angers, Le Kremlin-Bicêtre, Paris
2024-04-03
Active, closed
A Study to Assess IPN01194 When Administered Alone in Adults With Advanced Solid Tumours
NCT06305247Melanoma, Head and Neck Squamous Cell Carcinoma, Pancreatic Ductal Adenocarcinoma, Colorectal Cancer
Ipsen
Phase 1/2
36
Lyon, Paris, Saint-Herblain, Villejuif
2024-04-03
Recruiting
UNICANCER
Phase 2
420
Saint-Denis, Avignon, Dijon, Lille, Marseille, Nice, Nîmes, Paris
2024-04-03
Recruiting
Assistance Publique - Hôpitaux de Paris
Not applicable
160
Paris
2024-04-02
Recruiting
Evaluation of the Efficacy of "Lifespan Integration" (LI) Therapy in Patients With Complex Post-Traumatic Stress Disorder
NCT06535243Post-Traumatic Stress Disorder Complex, Psychiatric Disorder, Abuse Neglect, Abuse Physical
Centre Hospitalier St Anne
Not applicable
38
Paris
2024-04-01
Not yet open
ANRS, Emerging Infectious Diseases
Phase 3
322
Paris
2024-04-01
Not yet open
Assistance Publique - Hôpitaux de Paris
Phase 2/3
33
Paris
2024-04
Active, closed
Study of Ravulizumab in Immunoglobulin A Nephropathy (IgAN)
NCT06291376Immunoglobulin A Nephropathy, IgAN
DrugRavulizumab
Alexion Pharmaceuticals, Inc.
Phase 3
584
Amiens, Bayonne, Brest, Chambéry, Le Kremlin-Bicêtre, Marseille, Nantes, Paris
2024-03-29
Active, closed
Merck Sharp & Dohme LLC
Phase 1/2
230
Toulouse, Angers, Lille, Paris, Villejuif
2024-03-28
Recruiting
A Phase 1 Study of FT819 in B-cell Mediated Autoimmune Disease
NCT06308978Antineutrophilic Cytoplasmic Antibody (ANCA)- Associated Vasculitis (AAV), Idiopathic Inflammatory Myositis (IIM), Systemic Sclerosis (SSc), Systemic Lupus Erythematosus (SLE)
DrugsFT819·Fludara·Bendamustine·Cytoxan
Fate Therapeutics
Phase 1
244
Paris
2024-03-28
Active, closed
Juno Therapeutics, Inc., a Bristol-Myers Squibb Company
Phase 1
120
Lille, Paris
2024-03-28
Recruiting
TocILizumab in aorTitis in GCA (TILT)
NCT06271018Aortitis, Giant Cell Arteritis (GCA)
Groupe français d'étude des Maladies Inflammatoires de loeil
Observational
80
Paris
2024-03-27
Active, closed
Institut Curie
Phase 2
81
Paris, Saint-Cloud
2024-03-27
Recruiting
A Clinical Study of MK-4208/TERN-701 in Participants With Chronic Myeloid Leukemia (CML) (MK-4208-003/Tern701-1012/CARDINAL)
NCT06163430Leukemia, Myelogenous, Chronic, BCR-ABL Positive, Chronic Myeloid Leukemia, Chronic Phase, Chronic Myeloid Leukemia
DrugHS-10382
Terns, Inc., a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA)
Phase 1/2
330
Lyon, Bordeaux, Marseille, Nantes, Paris, Pierre-Bénite
2024-03-26
Recruiting
Italfarmaco
Phase 3
220
Saint-Quentin, Nice, Troyes, Tours, Nantes, Angers, Amiens, Paris
2024-03-26
Recruiting
Mitral
Not applicable
500
Aix-en-Provence, Antony, Bordeaux, Montpellier, Mulhouse, Paris, Reims, Roanne
2024-03-26
Recruiting
Genetic and Molecular Characterization of Nervous System Lesions
NCT06314607Brain Tumor, Brain Lesion (General)
Assistance Publique - Hôpitaux de Paris
Observational
10,000
Paris
2024-03-26
Recruiting
Assistance Publique - Hôpitaux de Paris
Not applicable
66
Paris
2024-03-26
Recruiting
Assistance Publique - Hôpitaux de Paris
Not applicable
80
Clichy, Nantes, Paris
2024-03-25
Recruiting
Assistance Publique - Hôpitaux de Paris
Observational
114
Paris
2024-03-25
Recruiting
Impact of Surgical Approach on Adaptation of Posture-respiratory Coupling
NCT06276530Resectable Lung Non-Small Cell Carcinoma
Assistance Publique - Hôpitaux de Paris
Not applicable
50
Paris
2024-03-25
Recruiting
Centre Hospitalier Departemental Vendee
Not applicable
206
La Roche-sur-Yon, La Rochelle, Le Puy-en-Velay, Limoges, Nantes, Paris, Reims, Rouen
2024-03-25
Recruiting
Assistance Publique - Hôpitaux de Paris
Observational
570
Paris
2024-03-25
Active, closed
Essilor International
Not applicable
150
Paris
2024-03-22
Recruiting
Molecure S.A.
Phase 2
96
Bobigny, Montpellier, Paris
2024-03-21
Active, closed
Thuasne
Not applicable
30
Paris
2024-03-21
Recruiting
Thrombo-inflammation Biomarkers Trial in Acute Cerebral Hypoxia
NCT04971564Cerebral Hypoxia, Ischemic Stroke
Fondation Ophtalmologique Adolphe de Rothschild
Observational
200
Paris
2024-03-19
Recruiting
Verastem, Inc.
Phase 3
270
Besançon, Dijon, Lille, Lyon, Paris
2024-03-18
Recruiting
European Organisation for Research and Treatment of Cancer - EORTC
Phase 3
411
Amiens, Clermont-Ferrand, Lille, Lyon, Montpellier, Nice, Paris, Saint-Herblain
2024-03-15
Recruiting
DMEK Endothelial Keratoplasty in Patients With a History of Anterior or Posterior Segment Surgery
NCT06013462Patients Undergoing DMEK With a History of Anterior or Posterior Segment Surgery
Fondation Ophtalmologique Adolphe de Rothschild
Observational
80
Paris
2024-03-15
Recruiting
Bedside Bone Biopsy in Diabetic Foot Osteomyelitis
NCT06066801Subjects With Diabetes and DFU With a Suspicion of DFO
Assistance Publique - Hôpitaux de Paris
Not applicable
320
Paris
2024-03-14
Recruiting
Eli Lilly and Company
Phase 3
90
Paris
2024-03-13
Recruiting
Janssen Research & Development, LLC
Phase 3
120
Amiens, Lille, Paris
2024-03-13
Recruiting
Characterization of High-Level Cognitive Impairments in Patients With Neuropsychiatric Disorders
NCT07295652Neurologic Disorders, Schizophrenia, Bipolar Disorder (BD), Depressive Disorder
Centre Hospitalier St Anne
Not applicable
600
Paris
2024-03-12
Recruiting
Novartis Pharmaceuticals
Phase 2
502
Paris, Pessac, Poitiers, Rennes
2024-03-07
Active, closed
Groupe Hospitalier Diaconesses Croix Saint-Simon
Not applicable
140
Paris
2024-03-07
Recruiting
Assistance Publique - Hôpitaux de Paris
Observational
1,200
Paris
2024-03-06
By invitation
Sarepta Therapeutics, Inc.
Phase 1/2
78
Angers, Bordeaux, Lille, Nice, Paris
2024-03-04
Recruiting
PTC Therapeutics
Phase 3
56
Lille, Paris, Tours
2024-03-04
Not yet open
Assistance Publique - Hôpitaux de Paris
Observational
100
Paris
2024-03
Not yet open
Ifenprodil as a ReMyelinating repurpOsed Drug in Multiple Sclerosis
NCT06330077Multiple Sclerosis, Remitting Relapsing Multiple Sclerosis
Assistance Publique - Hôpitaux de Paris
Phase 2
60
Bron, Paris
2024-03
Recruiting
Veno-arterial ExtraCorporeal Membrane Oxygenation to Reduce Morbidity and Mortality Following Lung TransPlant
NCT05664204The Number of Ventilator-free Days in the 28 Days Following LT
Assistance Publique - Hôpitaux de Paris
Not applicable
200
Paris, Suresnes
2024-02-29
Recruiting
Multimodal Study of the Human Brain Epilepsy Tissue
NCT06022055Focal Drug-resistant Epilepsy
Assistance Publique - Hôpitaux de Paris
Not applicable
300
Paris
2024-02-29
Active, closed
Sanofi
Phase 3
464
Bordeaux, Clermont-Ferrand, Créteil, Lille, Paris, Rouen, Saint-Pierre
2024-02-29
Recruiting
Mpact 3D Metal Monolit Study
NCT06748885Total Hip Arthroplasty (THA)
Medacta International SA
Observational
88
Nantes, Paris
2024-02-28
Recruiting
Novartis Pharmaceuticals
Phase 3
50
Bordeaux, Paris, Rouen, Toulouse, Tours
2024-02-28
Recruiting
DEprescribing: Perceptions of PAtients Living With Advanced Cancer
NCT06193083Deprescribing, Palliative Care, Oncology
Nantes University Hospital
Observational
325
La Roche-sur-Yon, Lyon, Nantes, Paris, Saint-Herblain, Saint-Nazaire, Tours
2024-02-28
Recruiting
University Hospital, Strasbourg, France
Observational
300
Bron, Paris, Strasbourg
2024-02-27
Recruiting
Centre Francois Baclesse
Not applicable
160
Caen, Clamart, Grenoble, Le Havre, Lyon, Nice, Paris, Saint-Cloud
2024-02-26
Recruiting
Fondation Ophtalmologique Adolphe de Rothschild
Observational
50
Nice, Paris
2024-02-26
Recruiting
Pulmonx Corporation
Not applicable
200
Limoges, Paris, Strasbourg, Toulouse
2024-02-22
Recruiting
Assistance Publique - Hôpitaux de Paris
Phase 3
470
Bordeaux, Boulogne-Billancourt, Créteil, Lyon, Nantes, Paris, Toulouse
2024-02-22
Active, closed
AstraZeneca
Phase 2
142
La Tronche, Marseille, Montpellier, Mulhouse, Paris, Pessac, Poitiers, Toulouse
2024-02-22
Active, closed
ViiV Healthcare
Phase 3
463
Bordeaux, Lyon, Montpellier, Nice, Nîmes, Paris
2024-02-21
Active, closed
Seagen, a wholly owned subsidiary of Pfizer
Phase 3
762
Besançon, Cholet, Créteil, Lille, Marseille, Montpellier, Paris, Pessac
2024-02-21
Recruiting
Assistance Publique - Hôpitaux de Paris
Not applicable
140
Paris
2024-02-20
Recruiting
Institut National de la Santé Et de la Recherche Médicale, France
Not applicable
82
Paris
2024-02-20
Active, closed
Study Evaluating Tarlatamab After Chemoradiotherapy in Limited-Stage Small-Cell Lung Cancer (LS-SCLC)
NCT06117774Limited Stage Small Cell Lung Cancer, Small Cell Lung Cancer
DrugTarlatamab
Amgen
Phase 3
404
Lille, Marseille, Nice, Paris, Villefranche-sur-Saône
2024-02-20
Active, closed
Vertex Pharmaceuticals Incorporated
Phase 1/2
47
Paris
2024-02-20
Recruiting
Assistance Publique - Hôpitaux de Paris
Observational
164
Paris
2024-02-19
Recruiting
Italfarmaco
Phase 3
138
Lille, Marseille, Paris
2024-02-19
Active, closed
argenx
Phase 2
103
Bordeaux, Créteil, La Tronche, Paris, Toulouse, Tours
2024-02-17
Active, closed
Janssen Research & Development, LLC
Phase 2
305
Marseille, Nice, Paris
2024-02-16
Recruiting
EGEA4 THE 30 YEAR FOLLOW UP OF THE EGEA STUDY
NCT06334705Healthy Volunteer EGEA4 Cohort
Institut National de la Santé Et de la Recherche Médicale, France
Not applicable
1,000
Grenoble, Lyon, Marseille, Montpellier, Paris
2024-02-15
Recruiting
Assistance Publique - Hôpitaux de Paris
Not applicable
60
Paris
2024-02-15
Recruiting
Assistance Publique - Hôpitaux de Paris
Not applicable
113
Paris
2024-02-14
Active, closed
Boehringer Ingelheim
Phase 1
69
Paris, Strasbourg, Villejuif
2024-02-14
Recruiting
argenx
Observational
100
Bordeaux, Bron, Lille, Marseille, Paris, Strasbourg
2024-02-13
Recruiting
Assistance Publique - Hôpitaux de Paris
Observational
100
Paris
2024-02-12
Active, closed
Boehringer Ingelheim
Phase 3
428
Bron, Lyon, Marseille, Paris, Rennes, Strasbourg, Toulouse, Villejuif
2024-02-09
Recruiting
Amryt Pharma
Phase 4
12
Lille, Paris, Pierre-Bénite
2024-02-08
Active, closed
Fondation Hôpital Saint-Joseph
Not applicable
352
Paris
2024-02-08
Recruiting
Evaluation of Integrated Versus Parallel Connection for Renal Replacement Therapy in ECMO Patients
NCT06038162Venoarterial Extracorporeal Membrane Oxygenation, Renal Replacement Therapy, Acute Kidney Injury
Hospices Civils de Lyon
Not applicable
158
Bordeaux, Clermont-Ferrand, Dijon, Grenoble, Lille, Lyon, Montpellier, Paris
2024-02-07
Recruiting
European Association of Cardiovascular Imaging Multiple and Mixed Valvular Disease Study
NCT06235385Heart Valve Diseases, Multiple Valve Disease, Unspecified, Aortic Valve Disease, Aortic Valve Stenosis
Assistance Publique - Hôpitaux de Paris
Observational
1,500
Paris
2024-02-07
Recruiting
Peripheral Serotonin and Albinism
NCT06138509Oculocutaneous Albinism
Assistance Publique - Hôpitaux de Paris
Observational
160
Paris
2024-02-06
Recruiting
Fetal Cell Receptors Repertoire
NCT06031714Venous Ulcer, Sickle Cell Ulcer, Diabetic Ulcer, Post-partum Women
Assistance Publique - Hôpitaux de Paris
Not applicable
160
Paris
2024-02-06
Active, closed
Genmab
Phase 3
1,095
Caen, Brest, Nantes, Avignon, Pierre-Bénite, Le Mans, Libourne, Paris
2024-02-05
Recruiting
Consciousness Prognosis Evaluation Using Olfactory Stimulations in Comatose Patients)
NCT07127224Disorders of Consciousness Due to Severe Brain Injury
Centre Hospitalier St Anne
Not applicable
96
Paris
2024-02-05
Recruiting
French COhoRte Extra-Vascular Implantable CardiovErter DefibrillatoR
NCT06739239Defibrillators, Implantable, Sudden Cardiac Death Due to Cardiac Arrhythmia
Paris Sudden Death Expertise Center
Observational
1,000
Paris
2024-02-01
Recruiting
FH ORTHO
Not applicable
92
Beaumont, Brest, Clichy, Garches, Haguenau, Nancy, Paris
2024-02-01
Active, closed
ReCode Therapeutics
Phase 2
128
Montpellier, Paris
2024-02-01
Recruiting
Deep rTMS (H-coil) for Neuropathic Pain or Fibromyalgia
NCT06250491Neuropathic Pain, Fibromyalgia
Nadine ATTAL
Not applicable
70
Boulogne-Billancourt, Paris
2024-01-30
Recruiting
Fondation Hôpital Saint-Joseph
Not applicable
100
Paris
2024-01-29
Recruiting
CarThera
Phase 3
560
Bron, Marseille, Paris, Suresnes
2024-01-29
Recruiting
Vividion Therapeutics, Inc.
Phase 1
280
Lyon, Montpellier, Paris, Toulouse, Villejuif
2024-01-25
Recruiting
Ibd CAncer and seRious Infections in France (I-CARE 2)
NCT06089590IBD, Ulcerative Colitis, Crohn Disease
Groupe d'Etude Therapeutique des Affections Inflammatoires Digestives
Observational
6,000
Amiens, Paris
2024-01-25
Recruiting
Ad scientiam
Not applicable
144
Garches, Grenoble, Lille, Nancy, Nantes, Paris, Strasbourg, Toulouse
2024-01-24
Recruiting
Juno Therapeutics, Inc., a Bristol-Myers Squibb Company
Phase 1
187
Paris
2024-01-23
Recruiting
Ascendis Pharma A/S
Phase 2
72
Paris
2024-01-23
Active, closed
Sanofi
Phase 3
260
Marseille, Nantes, Paris, Pessac, Pierre-Bénite, Rennes, Vandœuvre-lès-Nancy
2024-01-23
Recruiting
MRI Versus Ocular UltraSonography for a Non Contact Evaluation of Ocular Layers
NCT05300698Describe Ultrasound Matches and Disagreements Ocular and MRI
Fondation Ophtalmologique Adolphe de Rothschild
Observational
30
Paris
2024-01-23
Recruiting
Assistance Publique - Hôpitaux de Paris
Not applicable
50
Paris
2024-01-22
Active, closed
Janssen Research & Development, LLC
Phase 3
838
Lille, Limoges, Lyon, Marseille, Nantes, Paris, Pessac, Strasbourg
2024-01-22
Recruiting
Assistance Publique - Hôpitaux de Paris
Phase 3
54
Paris
2024-01-21
Recruiting
University Hospital, Toulouse
Not applicable
440
Amiens, Bordeaux, La Tronche, Le Kremlin-Bicêtre, Lille, Lyon, Nancy, Paris
2024-01-19
Rows per page Showing 1001–1500 of 2821
Previous 1 2 3 4 5 Next
Cite this view

Priya Life Science (2026). Clinical trial register: studies with a French investigative site, filtered. Derived from ClinicalTrials.gov. Retrieved 28 October 2026. https://priyalifescience.com/clinical-trials-france/city/paris?page=3

Query this register directly
GET /api/trials?country=in&status=recruiting&format=json Try it now →

About this register

This register is built from ClinicalTrials.gov, the trial registry run by the U.S. National Library of Medicine. It includes every study on the registry that lists at least one investigative site in France and is recruiting, not yet recruiting, active but no longer recruiting, or enrolling by invitation: 9,697 studies in total at the last sync on 26 Oct 2026, 03:20 UTC. The full list can be downloaded as CSV or queried as JSON through the register API.

This page shows the 2,821 of those studies with a site in Paris.

How many clinical trials are recruiting in Paris?

1,622 of the 2,821 studies on this page are recruiting new participants as of the 26 Oct 2026, 03:20 UTC sync. A further 321 have not yet opened recruitment, 831 are active but closed to new participants, and 47 are enrolling by invitation only. Eligibility for any study is decided by its study team.

Listing here is informational and not medical advice; eligibility is determined by each study team. See also the Ireland, UK, EU, USA and China registers.